General MedicationsOPHTHALMICStandard
PHOTREXA VISCOUS IN DEXTRAN 20%
RIBOFLAVIN 5'-PHOSPHATE
Standard Dose
0.146%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PHOTREXA VISCOUS IN DEXTRAN 20% is listed in Drugs@FDA under application 203324 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RIBOFLAVIN 5'-PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.146% Sponsor GLAUKOS Submission history Latest submission status date: 2025-02-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHOTREXA VISCOUS IN DEXTRAN 20% is listed in Drugs@FDA under application 203324 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RIBOFLAVIN 5'-PHOSPHATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.146% Sponsor GLAUKOS Submission history Latest submission status date: 2025-02-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.